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background: Long-term clinical outcomes after transcatheter closure of atrial septal defect (ASD) in adult patients remain unknown, especially in 
geriatric population. The aim of this study was to evaluate long-term outcomes among the different patient population over than 55 years of age.
Methods: A total of 212 patients were divided into 3 groups according to age at transcatheter closure of ASD (55-64 years: n = 89, 65-74 
years: n = 72, ≥75 years: n = 51). We assessed long-term outcomes and improvements in New York Heart Association functional class and cardiac 
remodeling after transcatheter closure of ASD.
results: As shown in figure, Kaplan-Meier analysis revealed that all-cause mortality (log-rank test, P = 0.385) and cardiovascular mortality (log-
rank test, P = 0.938) were not different among the 3 groups. Additionally, major events including all-cause mortality and hospitalization due to 
heart failure or stroke were not different among the 3 groups at least 5 years follow-up period (log-rank test, P = 0.208). New York Heart Association 
functional class (P <0.001) and right ventricular / left ventricular end-diastolic diameter ratio (P <0.001) improved after transcatheter closure of 
ASD in all the 3 groups.
conclusion: Although long-term clinical outcomes after transcatheter closure of ASD are still unknown, our results demonstrated that transcatheter 
closure of ASD has clinical implication even in patients over 75 years of age.
